# US 2024/0197653 A1 · Epinephrine compositions and containers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197653 A1
- Document ID: US20240197653A1
- Status: Published application
- Kind: A1
- Application number: 18/437,931
- Filed: 2024-02-09
- Published: 2024-06-20
- Earliest claimed: 2018-03-23
- Assignees: Nevakar Injectables Inc.
- Applicants: Nevakar Injectables Inc.
- Inventors: Prem Sagar AKASAPU; Kumaresh SOPPIMATH; Reema Ajitkumar PURI; louri V. Ilitchev; Milan PATEL; Pooja H. TENDULKAR
- Web page: https://patentgrep.com/patent/US20240197653A1

## CPC

- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 47/183: {Amino acids, e.g. glycine, EDTA or aspartame}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A ready-to-administer epinephrine composition having between about 0.005 and about 0.07 mg/mL epinephrine, at least about 0.9 wt % sodium chloride; between about 1 and about 50 ug/mL ethylenediaminetetraacetic acid; 0.005 wt % or less sodium metabisulfite, and water. Also included are systems having the composition contained in a container.

## Claims

### Claim 1

A pharmaceutical composition comprising:
between about 0.005 and about 0.07 mg/mL epinephrine;
at least about 0.9 wt % sodium chloride;
between about 1 and about 50 g/mL ethylenediaminetetraacetic acid;
0.005 wt % or less sodium metabisulfite; and
water,
wherein the pharmaceutical composition has a pH of between about 3.0 and about 5.5.

### Claim 2 (depends on 1)

The pharmaceutical composition according to claim 1, wherein the pH is between about 3.0 and about 5.0.

### Claim 3 (depends on 1)

The pharmaceutical composition according to claim 1, comprising about 0.016 mg/mL epinephrine.

### Claim 4 (depends on 1)

The pharmaceutical composition according to claim 1, comprising about 0.032 mg/mL epinephrine.

### Claim 5 (depends on 1)

The pharmaceutical composition according to claim 1, wherein the pharmaceutical composition comprises equal or less than 4% S-isomer content after storage of at least one month at 25° C.

### Claim 6 (depends on 1)

A system comprising the pharmaceutical composition according to claim 1 contained in a container.

### Claim 7 (depends on 6)

The system of claim 6, wherein the container comprises a polymeric material.

### Claim 8 (depends on 7)

The system of claim 7, wherein the polymeric material comprises polypropylene, polyethylene, or a combination thereof.

### Claim 9 (depends on 6)

The system of claim 6, wherein the container has a volume of at least about 100 mL.

### Claim 10 (depends on 6)

The system of claim 6, wherein the container has a volume of at least about 200 mL.
